Induction chemotherapy in head and neck center

Hematology/Oncology Clinics of North America

Volumn 13, Issue 4, 1999, Pages 689-698

  Adelstein, D J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; INTERFERON; METHOTREXATE;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOSENSITIVITY; HEAD AND NECK CANCER; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR REGRESSION;

EID: 0032838222     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70086-1     Document Type: Article

References (59)

1. D.J. Adelstein The community approach to salvage therapy for advanced head and neck cancer Semin Oncol 21 suppl 7 1994 52 57
2. D.J. Adelstein E.H. Tan P. Lavertu Treatment of head and neck cancer: The role of chemotherapy Crit Rev Oncol Hem 24 1996 97 116
3. M. Al-Sarraf Head and neck cancer: Chemotherapy concepts Semin Oncol 15 1988 70 85
4. M. Al-Sarraf J.A. Kish J.F. Ensley The Wayne State University experience with adjuvant chemotherapy of head and neck cancer Hematol Oncol Clin North Am 5 1991 687 700
5. I. Athanasiadis S. Taylor E.E. Vokes Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck Cancer 79 1997 588 594
6. J. Bourhis J.P. Pignon L. Designé Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): (1) Loco-regional treatment vs same treatment + chemotherapy (CT) [abstract] Proceedings of the American Society of Clinical Oncology 17 1998 386a
7. B.E. Brockstein E.E. Vokes Chemoradiotherapy for head and neck cancer PPO Updates/Principles & Practice of Oncology 10 1996
8. G.P. Browman Evidence-based recommendations against neoadjuvant chemotherapy for routine management of patients with squamous cell head and neck cancer Cancer Invest 12 1994 662 671
9. G.P. Browman L. Cronin Standard chemotherapy in squamous cell head and neck cancer: What we have learned from randomized trials Semin Oncol 21 1994 311 319
10. A.W. Brown J. Blom W.M. Butler Combination chemotherapy with vinblastine, bleomycin, and cis-diaminedichloroplatinum (II) in squamous cell carcinoma of the head and neck Cancer 45 1980 2830 2835
11. J.R. Clark P.M. Busse C.M. Norris Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: Long-term results J Clin Oncol 15 1997 3100 3110
12. J.R. Clark B.G. Fallon A.I. Dreyfuss Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancer Semin Oncol 15 suppl 3 1988 35 44
13. 0 disease Semin Oncol 16 suppl 6 1989 44 57
14. F. Cognetti P. Pinnarò P. Carlini Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer Cancer 62 1988 251 261
15. F. Cognetti P. Pinnarò E.M. Ruggeri Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer J Clin Oncol 7 1989 829 837
16. D. Dalley E. Beller R. Aroney The value of chemotherapy (CT) prior to definitive local therapy (DLT) in patients with locally advanced squamous cell carcinoma (SCC) of the head and neck (HN) [abstract] Proceedings of the American Society of Clinical Oncology 14 1995 297
17. D.A. Decker A. Drelichman J. Jacobs Adjuvant chemotherapy with cis-diaminodichloroplatinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck Cancer 51 1983 1353 1355
18. J. Depondt P. Gehanno M. Martin Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer Oncology 50 suppl 2 1993 23 27
19. B. DiBlasio W. Barbieri A. Bozzetti A prospective randomized trial in resectable head and neck carcinoma: Loco-regional treatment with and without neoadjuvant chemotherapy [abstract] Proceedings of the American Society of Clinical Oncology 13 1994 279
20. I.W. Dimery W.K. Hong Overview of combined modality therapies for head and neck cancer J Natl Cancer Inst 85 1993 95 111
21. Domenge C, Coche-Dequeant B, Wibault P, et al: Randomized trial of neoadjuvant chemotherapy before radiotherapy in oropharyngeal carcinoma [abstract 164]. In Proceedings of the Fourth International Conference on Head and Neck Cancer, Toronto, Canada, 1996, p 99
22. S. El-Sayed N. Nelson Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials J Clin Oncol 14 1996 838 847
23. J.F. Ensley J.R. Jacobs A. Weaver Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck Cancer 54 1984 811 814
24. J.F. Ensley Z. Maciorowski Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck Semin Oncol 21 1994 330 339
25. T.J. Ervin J.R. Clark R.R. Weichselbaum An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck J Clin Oncol 5 1987 10 20
26. E. Fonseca J.J. Cruz C.A. Rodriguez Phase III study of cisplatin plus 5-fluorouracil with or without folinic acid in locally advanced head and neck cancer (LAHNC) [abstract] Proceedings of the American Society of Clinical Oncology 16 1997 400a
27. A.A. Forastiere B. Metch D.E. Schuller Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group Study J Clin Oncol 10 1992 1245 1251
28. K.K. Fu Combined-modality therapy for head and neck cancer Oncology (Huntingt) 11 1997 1781 1796
29. P.M. Harari Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? J Clin Oncol 15 1997 2050 2055
30. Y. Hasegawa H. Matsuura M. Fukushima A randomized trial of neoadjuvant chemotherapy with cisplatin and 5-FU in advanced head and neck cancer [abstract] Proceedings of the American Society of Clinical Oncology 13 1994 286
31. B.T. Hill L.A. Price The role of adjuvant chemotherapy in the treatment of advanced head and neck cancer Acta Oncol 29 1990 695 703
32. C. Jacobs Adjuvant and neoadjuvant treatment of head and neck cancers Semin Oncol 18 1991 504 514
33. C. Jacobs G. Lyman E. Velez-Garcia A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck J Clin Oncol 10 1992 257 263
34. C. Jaulerry J. Rodriguez F. Brunin Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials Int J Radiat Oncol Biol Phys 23 1992 483 489
35. A. Jortay F. Demard O. Dalesio A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation. Results from 5 to 10 years Acta Chir Belg 90 1990 115 122
36. J.L. Lefebvre D. Chevalier B. Luboinski Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial J Natl Cancer Inst 88 1996 890 899
37. M. Martin A. Hazan L. Vergnes Randomized study of 5-fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: A preliminary report Int J Radiat Oncol Biol Phys 19 1990 973 975
38. J.J. Mazeron M. Martin B. Brun Induction chemotherapy in head and neck cancer: Results of a phase III trial Head Neck 14 1992 85 91
39. A.J. Munro An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer Br J Cancer 71 1995 83 91
40. A. Paccagnella A. Orlando C. Marchiori Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo J Natl Cancer Inst 86 1994 265 272
41. D.G. Pfister D. Bajorin R. Motzer Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer Arch Otolaryngol Head Neck Surg 120 1994 89 95
42. H.A. Pinto C. Jacobs Chemotherapy for recurrent and metastatic head and neck cancer Hematol Oncol Clin North Am 5 1991 667 686
43. M.R. Posner R.R. Weichselbaum T.J. Fitzgerald Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 11 1985 1887 1893
44. V.L. Randolph A. Vallejo R.H. Spiro Combination therapy of advanced head and neck cancer. Induction of remissions with diaminedichloroplatinum (II), bleomycin and radiation therapy Cancer 41 1978 460 467
45. J.M. Richard A. Kramer R. Molinari Randomized EORTC Head and Neck Cooperative Group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma Eur J Cancer 27 1991 821 827
46. M. Rooney J. Kish J. Jacobs Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-h 5-FU infusion and cisplatin Cancer 55 1985 1123 1128
47. P.M. Stell Adjuvant chemotherapy in head and neck cancer Semin Radiat Oncol 2 1992 195 205
48. R. Stupp R.R. Weichselbaum E.E. Vokes Combined modality therapy of head and neck cancer Semin Oncol 21 1994 349 358
49. I.F. Tannock G. Browman Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer J Clin Oncol 4 1986 1121 1126
50. M. Tejedor A. Murias P. Soria Induction chemotherapy with carboplatin and Ftorafur in advanced head and neck cancer Am J Clin Oncol 15 1992 417 421
51. R.J. Toohill T. Anderson R.W. Byhardt Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer Arch Otolaryngol Head Neck Surg 113 1987 758 761
52. S.E. Vogl H. Lerner B.H. Kaplan Failure of effective initial chemotherapy to modify the course of stage IV (M0) squamous cancer of the head and neck Cancer 50 1982 840 844
53. S.E. Vogl D.A. Schoenfeld B.H. Kaplan A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin and cisplatin in head and neck cancer Cancer 56 1985 432 442
54. E.E. Vokes D.J. Haraf J.M. McEvilly Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: A feasible and active approach Ann Oncol 3 1992 79 81
55. E.E. Vokes R.J. Schilsky R.R. Weichselbaum Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: A clinical and pharmacologic analysis J Clin Oncol 8 1990 241 247
56. E.E. Vokes R.R. Weichselbaum S.M. Lippman Head and neck cancer N Engl J Med 328 1993 184 194
57. Volling P, Schroeder M, Eckel H, et al: Results of a prospective randomized trial with induction chemotherapy in cancer of the oral cavity and the pharynx [abstract 484]. In Proceedings of the Fourth International Conference on Head and Neck Cancer, Toronto, Canada, 1996, p 179
58. G.T. Wolf W.K. Hong S.G. Fisher Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 324 1991 1685 1690
59. S.G. Urba A.A. Forastiere Systemic therapy of head and neck cancer: Most effective agents, areas of promise Oncology (Huntingt) 3 1989 79 88